DILH
PCRX icon

Dai-ichi Life Holdings’s Pacira BioSciences PCRX Stock Holding History

Dai-ichi Life Holdings’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-23,465
Closed -$1.35M – 664
2013
Q4 		$1.35M Sell
23,465
-25,854
-52% -$1.36M 0.04% 366
2013
Q3 		$2.37M Buy
+49,319
New +$1.8M 0.08% 273

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return

Dai-ichi Life Holdings's PCRX Position: Q1 2014 in Review

Dai-ichi Life Holdings sold out of Pacira BioSciences (PCRX) in Q1 2014, closing a stake of 23,465 shares — an estimated $1.35M sold.

Dai-ichi Life Holdings first reported a position in PCRX in Q3 2013 and held it in 2 quarters. The position peaked at $2.37M in Q3 2013. 160 funds tracked by Wall St. Rank hold PCRX as of Q1 2014.

  • Dai-ichi Life Holdings reported no remaining Pacira BioSciences position as of Q1 2014 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 23,465 Pacira BioSciences shares in Q1 2014, an estimated $1.35M.
  • Dai-ichi Life Holdings first reported a position in Pacira BioSciences in Q3 2013 and held it in 2 quarters.
  • Dai-ichi Life Holdings's Pacira BioSciences position peaked at $2.37M in Q3 2013.
  • 160 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2014.

Based on Dai-ichi Life Holdings's 13F filing for Q1 2014, filed 14 May 2014.